The IR 1152 mutant insulin receptor selectively impairs insulin action in skeletal muscle but not in liver

11Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

In patients harboring the IR 1152 mutant insulin receptor, hepatic glucose production was normally suppressed by insulin. Hepatocytes without the insulin receptor gene and expressing IR 1152 (Hep(MUT)) also showed normal insulin suppression of glucose production and full insulin response of glycogen synthase. In contrast, expression of the IR 1152 mutant in skeletal muscle maximally increased glucose uptake and storage, preventing further insulin stimulation. IRS-1 phosphorylation was normally stimulated by insulin in both intact Hep(MUT) and L6 skeletal muscle cells expressing the IR 1152 mutant (L6(MUT). At variance, IRS-2 phosphorylation exhibited high basal levels with no further insulin-dependent increase in L6(MUT) but almost normal phosphorylation, both basal and insulin-stimulated, in the Hep(MUT) cells. In vitro, IR 1152 mutant preparations from both the L6(MUT) and the Hep(MUT) cells exhibited increased basal and no insulin-stimulated phosphorylation of IRS-2 immobilized from either muscle or liver cells. IR 1152 internalization in liver and muscle cells closely paralleled the ability of this mutant to phosphorylate IRS-2 in vivo in these cells. Block of receptor internalization (wild-type and mutant) in the liver and muscle cells also inhibited IRS-2, but not IRS-1, phosphorylation. Thus, the mechanisms controlling insulin receptor internalization differ in liver and skeletal muscle cells and may enable IR 1152 to control glucose metabolism selectively in liver. In both cell types, receptor internalization seems necessary for IRS-2 but not IRS-1 phosphorylation.

References Powered by Scopus

THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

18457Citations
N/AReaders
Get full text

INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT

1458Citations
N/AReaders
Get full text

A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction

1274Citations
N/AReaders
Get full text

Cited by Powered by Scopus

A novel syndrome of autosomal-dominant hyperinsulinemic hypoglycemia linked to a mutation in the human insulin receptor gene

116Citations
N/AReaders
Get full text

Insulin resistance, defective insulin receptor substrate 2-associated phosphatidylinositol-3′ kinase activation, and impaired atypical protein kinase C (ζ/λ) activation in myotubes from obese patients with impaired glucose tolerance

102Citations
N/AReaders
Get full text

Activation and Mitochondrial Translocation of Protein Kinase Cδ Are Necessary for Insulin Stimulation of Pyruvate Dehydrogenase Complex Activity in Muscle and Liver Cells

64Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Caruso, M., Miele, C., Oliva, A., Condorelli, G., Oriente, F., Riccardi, G., … Beguinot, F. (2000). The IR 1152 mutant insulin receptor selectively impairs insulin action in skeletal muscle but not in liver. Diabetes. American Diabetes Association Inc. https://doi.org/10.2337/diabetes.49.7.1194

Readers' Seniority

Tooltip

Researcher 6

60%

Professor / Associate Prof. 2

20%

PhD / Post grad / Masters / Doc 2

20%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 6

55%

Biochemistry, Genetics and Molecular Bi... 3

27%

Medicine and Dentistry 1

9%

Psychology 1

9%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free